Intellia Therapeutics (NTLA) PT Lowered to $18 at Baird
Tweet Send to a Friend
(Updated - October 24, 2024 9:43 AM EDT)
Baird analyst Jack Allen lowered the price target on Intellia Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Jack Allen lowered the price target on Intellia Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
